Tissue type-specific modulation of ER transcriptional activity by NFAT3

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 576-581

  Zhang, Hao ^a   Wang, Xiaohui ^a   Li, Jieping ^a   Zhu, Jianhua ^b   Xie, Xiangyang ^a   Yuan, Bin ^a   Yang, Zhihong ^a   Zeng, Min ^c   Jiang, Zefei ^c   Li, Jiezhi ^a   Huang, Cuifen ^a   Ye, Qinong ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c Beijing 307 Hospital   (China)

Author keywords

ER; NFAT3; Tissue specific; Transcription

Indexed keywords

ALANINE; AMINO ACID; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGAND; SERINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; DELETION MUTANT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; KIDNEY; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; SERINE; TRANSFECTION; TUMOR CELLS, CULTURED; WILMS TUMOR;

EID: 33846031538     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.046     Document Type: Article

References (32)

1. Kazi A.A., Jones J.M., and Koos R.D. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor α and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol. Endocrinol. 19 (2005) 2006-2019
2. Audesirk T., Cabell L., Kern M., and Audesirk G. β-Estradiol influences differentiation of hippocampal neurons in vitro through an estrogen receptor-mediated process. Neuroscience 121 (2003) 927-934
3. Windahl S.H., Andersson G., and Gustafsson J.A. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol. Metab. 13 (2002) 195-200
4. Gillies G.E., Murray H.E., Dexter D., Gillies G.E., Murray H.E., Dexter D., and McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol. Biochem. Behav. 78 (2004) 513-522
5. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., and Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89 (1994) 1501-1510
6. Henderson B.E., and Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 21 (2000) 427-433
7. Bramlett K.S., and Burris T.P. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells. J. Steroid Biochem. Mol. Biol. 86 (2003) 27-34
8. Burger H.G. Selective oestrogen receptor modulators. Horm. Res. 53 (2000) 25-29
9. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 65 (2000) 227-251
10. Dobrzycka K.M., Townson S.M., Jiang S., and Oesterreich S. Estrogen receptor corepressors-a role in human breast cancer?. Endocr. Relat. Cancer 10 (2003) 517-536
11. Graham J.D., Bain D.L., Richer J.K., Jackson T.A., Tung L., and Horwitz K.B. Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer. Steroids 65 (2000) 579-584
12. Shang Y., and Brown M. Molecular determinants for the tissue specificity of SERMs. Science 295 (2002) 2465-2468
13. Lamb J., Ladha M.H., McMahon C., Sutherland R.L., and Ewen M.E. Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol. Cell. Biol. 20 (2000) 8667-8675
14. Gayther S.A., Warren W., Mazoyer S., Russell P.A., Harrington P.A., Chiano M., Seal S., Hamoudi R., van Rensburg E.J., Dunning A.M., Love R., Evans G., Easton D., Clayton D., Stratton M.R., and Ponder B.A. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat. Genet. 11 (1995) 428-433
15. Tilli M.T., Reiter R., Oh A.S., Henke R.T., McDonnell K., Gallicano G.I., Furth P.A., and Riegel A.T. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Mol. Endocrinol. 19 (2005) 644-656
16. Liu Z., Auboeuf D., Wong J., Chen J.D., Tsai S.Y., Tsai M.J., and O'Malley B.W. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc. Natl. Acad. Sci. USA 99 (2002) 7940-7944
17. Ding L., Yan J., Zhu J., Zhong H., Lu Q., Wang Z., Huang C., and Ye Q. Ligand-independent activation of estrogen receptor alpha by XBP-1. Nucleic Acids Res. 31 (2003) 5266-5274
18. Zhang H., Xie X., Zhu X., Zhu J., Hao C., Lu Q., Ding L., Liu Y., Zhou L., Liu Y., Huang C., Wen C., and Ye Q. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. J. Biol. Chem. 280 (2005) 43188-43197
19. Yang T.T., Xiong Q., Enslen H., Davis R.J., and Chow C.W. Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol. Cell. Biol. 22 (2002) 3892-3904
20. Sarker K.P., Wilson S.M., and Bonni S. SnoN is a cell type-specific mediator of transforming growth factor-beta responses. J. Biol. Chem. 280 (2005) 13037-13046
21. Tynan S.H., Lundeen S.G., and Allan G.F. Cell type-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen. J. Steroid Biochem. Mol. Biol. 91 (2004) 225-239
22. Carcamo J., Zentella A., and Massague J. Disruption of transforming growth factor β signaling by a mutation that prevents stransphosphorylation within the receptor complex. Mol. Cell Biol. 15 (1995) 1573-1581
23. Shao W., Halachmi S., and Brown M. ERAP140, a conserved tissue-specific nuclear receptor coactivator. Mol. Cell. Biol. 22 (2002) 3358-3372
24. Thiriet C., and Hayes J.J. Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol. Cell 18 (2005) 617-622
25. Chen L.F., and Greene W.C. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med. 81 (2003) 549-557
26. Meek D.W., and Knippschild U. Posttranslational modification of MDM2. Mol. Cancer Res. 1 (2003) 1017-1026
27. Uno F., Sasaki J., Nishizaki M., Carboni G., Xu K., Atkinson E.N., Kondo M., Minna J.D., Roth J.A., and Ji L. Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res. 64 (2004) 2969-2976
28. Montpetit B., Hazbun T.R., Fields S., and Hieter P. Sumoylation of the budding yeast kinetochore protein Ndc10 is required for Ndc10 spindle localization and regulation of anaphase spindle elongation. J. Cell Biol. 174 (2006) 653-663
29. He C., Hus J.C., Sun L.J., Zhou P., Norman D.P., Dotsch V., Wei H., Gross J.D., Lane W.S., Wagner G., and Verdine G.L. A methylation-dependent electrostatic switch controls DNA repair and transcriptional activation by E. coli ada. Mol. Cell 20 (2005) 117-129
30. Sun J., Duffy K.E., Ranjith-Kumar C.T., Xiong J., Lamb R.J., Santos J., Masarapu H., Cunningham M., Holzenburg A., Sarisky R.T., Mbow M.L., and Kao C. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J. Biol. Chem. 281 (2006) 11144-11151
31. Passier R., Zeng H., Frey N., Naya F.J., Nicol R.L., McKinsey T.A., Overbeek P., Richardson J.A., Grant S.R., and Olson E.N. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105 (2000) 1395-1406
32. Liao W., Wang S., Han C., and Zhang Y. 14-3-3 Proteins regulate glycogen synthase 3β phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J. 272 (2005) 1845-1854